Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -12.45 is 519% below its 5-year average of -2.01, near the low end of its 5-year range (-12.45–3.05).
165.74% below its 12-month average of -4.69.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:40:25.440Z. Historical observations retain their original dates. Historical series through 2026-02-26.
EARNINGS PER SHARE (EPS)
-12.45
EARNINGS PER SHARE (EPS) AVG TTM
-4.69
EARNINGS PER SHARE (EPS) AVG 3Y
-1.64
EARNINGS PER SHARE (EPS) AVG 5Y
-2.01
EARNINGS PER SHARE (EPS) AVG 10Y
-0.79
EARNINGS PER SHARE (EPS) AVG 15Y
0.89
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-165.74%
CURRENT VS 3Y AVG
-659.15%
CURRENT VS 5Y AVG
-519.40%
CURRENT VS 10Y AVG
-1472.33%
CURRENT VS 15Y AVG
-1496.63%
CURRENT VS 20Y AVG
N/A
Acadia Healthcare Company, Inc.
Market Cap
$2.69B
Earnings Per Share (EPS)
-12.45
TTM Avg
-4.69
3Y Avg
-1.64
5Y Avg
-2.01
Market Cap
$2.70B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
Market Cap
$2.71B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.45
3Y Avg
-0.45
5Y Avg
-0.45
Market Cap
$2.72B
Earnings Per Share (EPS)
1.26
TTM Avg
1.10
3Y Avg
0.11
5Y Avg
-0.77
Market Cap
$2.65B
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.56
3Y Avg
-1.52
5Y Avg
-1.27
Market Cap
$2.86B
Earnings Per Share (EPS)
-3.33
TTM Avg
-3.42
3Y Avg
-3.51
5Y Avg
-3.03
Market Cap
$2.87B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.59
3Y Avg
-0.72
5Y Avg
-0.48
Market Cap
$2.89B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.45B
Earnings Per Share (EPS)
1.37
TTM Avg
-1.23
3Y Avg
-1.08
5Y Avg
-1.13
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Healthcare Company, Inc. (ACHC) | $2.69B | -12.45 | -4.69 | -1.64 | -2.01 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.70B | -0.86 | -2.70 | -2.81 | -3.40 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.71B | N/A | -0.45 | -0.45 | -0.45 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.72B | 1.26 | 1.10 | 0.11 | -0.77 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.65B | -1.04 | -1.56 | -1.52 | -1.27 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.86B | -3.33 | -3.42 | -3.51 | -3.03 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 0.21 | -0.59 | -0.72 | -0.48 |
| TransMedics Group, Inc. (TMDX)vs › | $2.89B | 3.86 | 3.33 | 1.17 | 0.32 |
| Liquidia Corporation (LQDA)vs › | $2.45B | 1.37 | -1.23 | -1.08 | -1.13 |
| Disc Medicine, Inc. (IRON)vs › | $2.44B | -6.60 | -4.98 | -14.61 | -21.72 |
Trailing EPS (TTM)
$-12.45
Forward EPS (Est.)
$1.53
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -12.16 |
| 2024-12-31 | 2.79 |
| 2023-12-31 | -0.24 |
| 2022-12-31 | 3.05 |
| 2021-12-31 | 2.15 |
| 2020-12-31 | -7.65 |
| 2019-12-31 | 1.24 |
| 2018-12-31 | -2.01 |
| 2017-12-31 | 2.30 |
| 2016-12-31 | 0.07 |
| 2015-12-31 | 1.75 |
| 2014-12-31 | 1.51 |
| 2013-12-31 | 0.85 |
| 2012-12-31 | 0.53 |
| 2011-12-31 | -1.86 |
| 2010-12-31 | 0.35 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T13:40:25.440Z. Historical observations retain their original dates. Historical series through 2026-02-26.
